Furthermore, by using the online bioinformatics tool Kaplan-Meier plotter [28], we found that GC patients with LATS1 low expression developed poorer survival (Fig. 2e) and more frequent recurrence (Fig. 2g). Here, LATS1 is linked to gastric cancer.